Success Metrics

Clinical Success Rate
92.6%

Based on 25 completed trials

Completion Rate
93%(25/27)
Active Trials
4(9%)
Results Posted
8%(2 trials)
Terminated
2(4%)

Phase Distribution

Ph not_applicable
24
51%
Ph phase_1
3
6%
Ph phase_3
3
6%
Ph phase_2
2
4%
Ph phase_4
3
6%

Phase Distribution

3

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution35 total trials
Phase 1Safety & dosage
3(8.6%)
Phase 2Efficacy & side effects
2(5.7%)
Phase 3Large-scale testing
3(8.6%)
Phase 4Post-market surveillance
3(8.6%)
N/ANon-phased studies
24(68.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

25 of 30 finished

Non-Completion Rate

16.7%

5 ended early

Currently Active

4

trials recruiting

Total Trials

47

all time

Status Distribution
Active(6)
Completed(25)
Terminated(5)
Other(11)

Detailed Status

Completed25
unknown11
Recruiting3
Withdrawn3
Terminated2
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
47
Active
4
Success Rate
92.6%
Most Advanced
Phase 4

Trials by Phase

Phase 13 (8.6%)
Phase 22 (5.7%)
Phase 33 (8.6%)
Phase 43 (8.6%)
N/A24 (68.6%)

Trials by Status

completed2553%
recruiting36%
unknown1123%
withdrawn36%
terminated24%
active_not_recruiting12%
not_yet_recruiting24%

Recent Activity

Clinical Trials (47)

Showing 20 of 47 trialsScroll for more
NCT07496905Not Applicable

The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial

Recruiting
NCT07265505Not Applicable

Study of Endometrial Immune and Microbiological Modifications in Cases of Recurrent Implantation Failure and/or Recurrent Pregnancy Loss

Not Yet Recruiting
NCT03955978Phase 1

TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial Cancer

Active Not Recruiting
NCT05095597Phase 2

Umbilical Cord Plasma for Treating Endometrial Pathologies (Thin Endometrium / Asherman's Syndrome/ Endometria Atrophy)

Completed
NCT07182643

Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients

Not Yet Recruiting
NCT01697566Phase 3

An Endometrial Cancer Chemoprevention Study of Metformin

Completed
NCT02630823Phase 1

MK-3475 Immunotherapy in Endometrial Carcinoma

Completed
NCT06450301

Senescent Endometrial Cells in Patients with Thin Endometrial Lining

Recruiting
NCT04107129

Predicting Endometrial Receptivity for Optimal Reproductive Management

Completed
NCT05405686Phase 4

Effect of LH Supplementation on the Endometrial Gene Expression Profile in Poor Ovarian Responders

Withdrawn
NCT04867759

Uterine Natural Killer (uNK) Cell Expression in Patients With Repeated ICSI Failures: A Multicenter Cohort Study

Recruiting
NCT04141085

Transcriptomic Evaluation of Endometrial Receptivity

Completed
NCT02197923

Norwegian Adenomyosis Study II: Gene Expression Profiling of Adenomyosis

Unknown
NCT02713854Not Applicable

BAP-EB as a Predictive Tool for Endometrial Receptivity and Pregnancy Outcome of IVF Treatment

Completed
NCT04860310

Panoramic Presentation and Tolerance Mechanism of Human Endometrium Based on Tiangui Theory

Completed
NCT03545945Not Applicable

Hysteroscopy in Chronic Anovulation

Withdrawn
NCT02646930Not Applicable

Chronic Endometritis and IVF

Completed
NCT04079959

Endometrial Leucocytes Around the Time of Embryo Implantation in Women Undergoing in IVF-ET

Unknown
NCT02522806Not Applicable

Endometrial Local Injury Before First IVF : Evaluation of Pregnancy Rate

Completed
NCT03157765Not Applicable

Trial of Endometrial Scratch Prior to Frozen Embryo Transfer in Patients With Recurrent Implantation Failure

Withdrawn

Drug Details

Intervention Type
PROCEDURE
Total Trials
47